HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ecolab

This article was originally published in The Rose Sheet

Executive Summary

Endure Revitalizing Skin Lotion and Crème responds to the skin-care needs of the healthcare industry, relieving the dry skin and contact dermatitis that comes from frequent hand washing without the use of petroleum-based lubricants that can compromise the barrier properties of latex and non-latex gloves, St. Paul, Minn. company announces Feb. 15. In addition, the products are formulated without common lotion additives that could compromise the efficacy of antimicrobial hand-washing products used in the healthcare industry. Both the lotion and crème are non-greasy, water-based formulas enriched with SymRepair, a conditioner that improves the skin's barrier function. The items also feature hyaluronic acid among other emollients, humectants and moisturizers, the company says...

You may also be interested in...



Recordati Raises Forecast for Isturisa After Smooth Launches

The Italian firm's move to license Isturisa from Novartis last year is paying dividends already and Recordati has already tripled its peak sales forecast for the Cushing's therapy.

Progress In Pharma’s Slow Battle Against A Deadly Infant Virus

Pfizer is up against AstraZeneca and Sanofi in developing competing approaches to tackling the unmet need in respiratory syncytial virus (RSV). But earlier failures mean all players will need much more data to sway regulators.

Global Medtech Guidance Tracker: July 2020

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Fifty-two guidance documents have been posted on the tracker since its last update.

UsernamePublicRestriction

Register

ID1122434

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel